Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.
Press releases published on June 11, 2025
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma
GlobeNewswire
·
June 11, 2025
FLORHAM PARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced initial results …
In Rare Double Win Optimal Dynamics Brings Home Two 2025 SupplyTech Breakthrough Awards For “Fleet Management Company of the Year” and “AI-based SupplyTech Solution of the Year”
GlobeNewswire
·
June 11, 2025
LOS ANGELES, June 11, 2025 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products and services in the supply chain technology and logistics …
OSS’s BRESSNER Receives the 2024 EMEA Growth Partner of the Year Award from Digi International
GlobeNewswire
·
June 11, 2025
ESCONDIDO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS) today announced that its subsidiary, BRESSNER Technology GmbH, a leading specialized high-performance computing supplier in Europe, has been …
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
June 11, 2025
BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has …
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
GlobeNewswire
·
June 11, 2025
SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, …
Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
GlobeNewswire
·
June 11, 2025
-- PCRX-201 demonstrated sustained clinical efficacy with improvements in pain, stiffness, and function for up to three years – BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery …
ImmuneWalk Therapeutics Announces Positive Topline Phase 1 SAD Data for Immunology and Inflammation Drug Candidate IW-601
GlobeNewswire
·
June 11, 2025
Study met primary endpoint of safety and tolerability at all doses and secondary pharmacodynamic and pharmacokinetic endpoints after single subcutaneous administration Pharmacodynamics provides mechanistic validation, demonstrating dose-dependent binding …
Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
GlobeNewswire
·
June 11, 2025
GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing precision treatments for addiction and related disorders, today …
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer
GlobeNewswire
·
June 11, 2025
ALAMEDA, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of Anthony …
Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders
GlobeNewswire
·
June 11, 2025
Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disorders Agreement is built on a partnership initiated in 2022, supporting continued development led by positive …
Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
GlobeNewswire
·
June 11, 2025
—Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential Strategic Partners Continue— TEL AVIV, Israel, June 11, 2025 ( …
RTI Connext Receives Industry Recognition as Leading Data Platform for Autonomous Systems
GlobeNewswire
·
June 11, 2025
SUNNYVALE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the software framework company for physical AI systems, today announced that RTI Connext® has been selected as the winner of the Top Unmanned Systems Data Processing and …
Repeat: Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients
GlobeNewswire
·
June 11, 2025
Updated AI-powered OSCE platform launched to enhance medical education delivery and evaluation. Successfully deployed at University of Minnesota with 240 students and potential of ~40% cost savings. Features AI-simulated patients and real-time scoring to …
BigCommerce Earns 2025 Top Rated Award from TrustRadius
GlobeNewswire
·
June 11, 2025
AUSTIN, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors, today announced that TrustRadius has recognized …
vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series
GlobeNewswire
·
June 11, 2025
HIGH POINT, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being …
List Of Technologically Progressive Featured Winners Represent Excellence In 2025 SupplyTech Breakthrough Awards Program
GlobeNewswire
·
June 11, 2025
LOS ANGELES, June 11, 2025 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products and services in the supply chain technology and logistics …
Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing
GlobeNewswire
·
June 11, 2025
Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib in 2026 On track to report results from three pivotal trials this year, beginning with SUMMIT results in July WALTHAM, Mass. and …
uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer
GlobeNewswire
·
June 11, 2025
~ Proven biotech executive to lead commercialization of AMT-130 in Huntington’s disease ~ LEXINGTON, Mass. and AMSTERDAM, June 11, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for …
House of Doge Appoints Fintech Leaders as CEO and Chief Payments Officer to Lead Global Expansion into Payments
GlobeNewswire
·
June 11, 2025
MIAMI, June 11, 2025 (GLOBE NEWSWIRE) -- House of Doge, the official corporate arm of the Dogecoin Foundation, today announced the appointment of Marco Margiotta as Chief Executive Officer and Ryan Deslippe as Chief Payments Officer. The two fintech …
June Market Trends Favor Pi, XRP & SOL – ALL4 Cloud Mining Positioned to Capitalize on Growth
GlobeNewswire
·
June 11, 2025
Philadelphia, Pennsylvania, June 11, 2025 (GLOBE NEWSWIRE) -- As the price of Bitcoin surges to over $100,000, altcoins are growing in popularity, with projects like Pi Network, XRP, and Solana gaining attention, and ALL4 Mining cloud mining has also …